EssilorLuxottica EL
ParisMedical instruments and suppliesFinancials to Sep 30, 2026 · Updated Nov 11, 2026
Moat ranks
Balance sheet
| €B | Dec 31 | Jun 30 |
|---|---|---|
| Cash | 3.5 | 1.9 |
| Securities | 0.0 | 0.0 |
| Debt | 10.8 | 11.4 |
| Net cash | -7.3 | -9.5 |
| Equity | 38.9 | 39.2 |
- Debt / EBITDA
- 1.67×
- Debt / equity
- 0.29×
- Leases (6/30/26)
- €3.9B
- Diluted shares
- 464M
- Book value / share
- €84.44
- Price / book
- 2.2×
- Net cash / share
- −€20.41
- Market cap
- €86.0B
- Enterprise value
- €95.5B
Per-share record
Key indicators
| Indicator | Latest | Vs year ago | Last 8 halves |
|---|---|---|---|
| Revenue growth | 5.7% | +0.1 pts | |
| Operating margin | 15.5% | +1.2 pts | |
| FCF margin | 10.3% | -0.0 pts | |
| Capex / revenue | 4.4% | -0.8 pts | |
| Comparable-store sales growth | +7% | – | |
| Retail stores · 8/31/26 | ~20,000 | – | |
| Wholesale customers · 12/31/25 | ≥300,000 | – | – |
| Professional Solutions revenue · 9/30/26 | €3.4B | – | |
| Royalty expense · 12/31/25 | €249M | -1% |
Margins and growth from reported quarters; company KPIs as reported in results releases.
About EL
EssilorLuxottica makes spectacle lenses, frames, sunglasses and smart glasses, and sells through professionals and its own retail network. FY2025 revenue was EUR28.491 billion, split 47.7% Professional Solutions and 52.3% Direct to Consumer.
- Distribution Control
Scale and embedded relationships with eye care professionals, supported by integrated manufacturing and distribution, help reach and service a broad installed base of optical doors.
- Brand Trust
Iconic proprietary brands drive consumer preference and willingness-to-pay, supporting premium positioning across sunglasses and prescription eyewear.
- Distribution Control
Owned retail and direct e-commerce (brand sites and marketplaces) increase reach and data capture, and allow tighter control of merchandising and launches.
- Contractual Exclusivity
Licensing partnerships with leading fashion houses broaden premium assortment and can create quasi-exclusive access to brand IP for eyewear categories during contract terms.
- Sep 9, 2026
The board unanimously reaffirmed confidence in Francesco Milleri, Paul du Saillant and the group strategy after public criticism, preserving management continuity while highlighting governance tension.
- Aug 28, 2026
EssilorLuxottica launched a program to buy up to 5 million shares, creating another use of cash; the release did not specify a cancellation.
- Aug 20, 2026
A US randomized trial published in JAMA Ophthalmology reported that Stellest lenses slowed childhood myopia progression by 71% over two years, supporting the product's clinical differentiation.
- Apr 2, 2026
EssilorLuxottica acquired a meaningful stake in Top Charoen, adding Thailand's nearly 2,000-store chain to its retail reach.
Ownership
Go deeper on EL
- Compare stock research toolsFundamentals, valuation and screening platforms for EL.19 tools
- See EL's price chartNo price chart here yet. See price history and indicators.17 tools
- Read EL's earnings callsTranscripts and audio of results calls, with management's own words.15 tools
- Investing tool dealsCurrent discounts on research, charting and tracking tools.98 deals
On this page
Financial record
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | Trend | Change 2016–25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Per share (€) | |||||||||||||
| Revenue | 41.03 | 41.62 | 40.69 | 39.42 | 32.87 | 44.49 | 54.96 | 56.34 | 57.62 | 61.31 | 63.06 | +4.6%/yr | |
| Cash flow | 5.92 | 7.26 | 8.86 | 7.48 | 6.73 | 10.20 | 10.73 | 10.78 | 10.60 | 11.39 | 11.38 | +7.5%/yr | |
| Earnings | 3.84 | 4.71 | 4.07 | 2.44 | 0.19 | 3.25 | 4.83 | 5.08 | 5.13 | 4.98 | 5.37 | +2.9%/yr | |
| Free cash flow | 2.95 | 4.26 | 6.19 | 5.43 | 5.25 | 7.89 | 7.21 | 7.39 | 7.29 | 8.10 | 8.27 | +11.9%/yr | |
| Capex | 2.97 | 3.01 | 2.67 | 2.05 | 1.48 | 2.31 | 3.53 | 3.40 | 3.31 | 3.28 | 3.11 | +1.1%/yr | |
| Dividends | 1.94 | 1.99 | 1.82 | 2.01 | 1.15 | 0.31 | 1.02 | 1.08 | 2.53 | 1.18 | 3.59 | -5.4%/yr | |
| Book value | 26.10 | 26.32 | 123.57 | 78.88 | 73.50 | 78.71 | 84.04 | 84.83 | 87.77 | 83.69 | 84.44 | +13.8%/yr | |
| Diluted shares (M) | 221 | 221 | 266 | 441 | 439 | 445 | 446 | 451 | 460 | 465 | 464 | +8.6%/yr | |
| Totals (€B) | |||||||||||||
| Revenue | 9.1 | 9.2 | 10.8 | 17.4 | 14.4 | 19.8 | 24.5 | 25.4 | 26.5 | 28.5 | 29.3 | +13.5%/yr | |
| Operating income | 1.3 | 1.3 | 1.4 | 1.7 | 0.5 | 2.3 | 3.2 | 3.2 | 3.4 | 3.4 | 3.7 | +10.8%/yr | |
| Net income | 0.9 | 1.0 | 1.1 | 1.1 | 0.1 | 1.4 | 2.2 | 2.3 | 2.4 | 2.3 | 2.5 | +11.8%/yr | |
| Free cash flow | 0.7 | 0.9 | 1.6 | 2.4 | 2.3 | 3.5 | 3.2 | 3.3 | 3.4 | 3.8 | 3.8 | +21.5%/yr | |
| Buybacks | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | 0.5 | 0.3 | 0.3 | 0.5 | 1.0 | +8.8%/yr | |
| Dividends | 0.4 | 0.4 | 0.5 | 0.9 | 0.5 | 0.1 | 0.5 | 0.5 | 1.2 | 0.5 | 1.7 | +2.7%/yr | |
| Net cash | -1.1 | -0.7 | -1.9 | -2.4 | -1.3 | -6.7 | -7.1 | -5.9 | -7.3 | -7.3 | -9.5 | −€6.2B | |
| Margins & returns (%) | |||||||||||||
| Gross margin | 65.3 | 64.9 | 63.4 | 62.2 | 56.7 | 61.7 | 63.6 | 63.2 | 63.4 | 60.6 | 60.8 | -4.7 pts | |
| Operating margin | 14.8 | 14.7 | 12.9 | 9.6 | 3.1 | 11.6 | 12.9 | 12.5 | 13.0 | 11.9 | 12.5 | -2.9 pts | |
| Net margin | 9.4 | 11.3 | 10.0 | 6.2 | 0.6 | 7.3 | 8.8 | 9.0 | 8.9 | 8.1 | 8.5 | -1.2 pts | |
| FCF margin | 7.2 | 10.2 | 15.2 | 13.8 | 16.0 | 17.7 | 13.1 | 13.1 | 12.6 | 13.2 | 13.1 | +6.0 pts | |
| ROIC | 15.0 | 16.0 | 3.1 | 3.5 | 1.0 | 4.3 | 5.5 | 5.6 | 5.6 | 5.7 | 5.8 | -9.4 pts | |
| Return on equity | 14.7 | 17.9 | 3.3 | 3.1 | 0.3 | 4.1 | 5.7 | 6.0 | 5.8 | 6.0 | 6.4 | -8.8 pts | |
| R&D % of revenue | – | 0.7 | 1.8 | 3.2 | 3.8 | 2.9 | 2.4 | 2.3 | 2.4 | 2.3 | 2.3 | – | |
| Stock pay % of revenue | 0.1 | 0.0 | 0.8 | 1.0 | 1.2 | 1.1 | 0.8 | 0.9 | 0.8 | 1.2 | 1.0 | +1.1 pts | |
| Capex % of revenue | 7.2 | 7.2 | 6.6 | 5.2 | 4.5 | 5.2 | 6.4 | 6.0 | 5.7 | 5.4 | 4.9 | -1.9 pts | |
Change uses 2016 and 2025 only: compound annual growth for amounts, points for margins and returns, and the change in amount for net cash. A dash means no 2016 base. Trend shows the fiscal years.
Moat
Moat scorecard
- Strength
- Confidence
- Structure
- Competitive
- Durability
- medium
- Trajectory
- stable
- Pricing power
- moderate
- Professional Solutions47.7%1 claim
- Direct to Consumer52.3%3 claims
Moat claims
- Applies to
- Professional Solutions
- Confidence
- Durability
- medium
- Trajectory
- stableas of Oct 7, 2026
Scale and embedded relationships with eye care professionals, supported by integrated manufacturing and distribution, help reach and service a broad installed base of optical doors.
Professional Solutions revenue rose 7.8% at constant exchange rates in H1 2026, supporting channel reach, but no evidence shows that its more than 300,000 wholesale customers are exclusive.
- Wholesale customers≥300,000
- Professional Solutions revenue€3.4B
- Consolidation of optical chains increasing buyer power
- DTC share gains reducing ECP channel influence
- Regulatory/antitrust constraints on distribution practices
- FilingEssilorLuxottica 2025 Universal Registration Document (Professional Solutions)Mar 6, 2026
- SourceStellest US clinical trial publicationAug 27, 2026
- Applies to
- Direct to Consumer
- Confidence
- Durability
- durable
- Trajectory
- stableas of Oct 7, 2026
Iconic proprietary brands drive consumer preference and willingness-to-pay, supporting premium positioning across sunglasses and prescription eyewear.
Ray-Ban and Oakley accounted for around 15% and more than 5% of 2025 group sales, while H1 2026 AI-glasses demand remained positive; pricing and brand retention are not disclosed.
- Comparable-store sales growth+7%
- Fashion cycle shifts and brand fatigue
- Counterfeiting and grey-market leakage
- Reputational damage from product quality or controversies
- FilingEssilorLuxottica 2025 Universal Registration Document (Brand portfolio)Mar 6, 2026
- SourceEssilorLuxottica Q2 and H1 2026 press releaseJul 28, 2026
- Applies to
- Direct to Consumer
- Confidence
- Durability
- medium
- Trajectory
- wideningas of Oct 7, 2026
Owned retail and direct e-commerce (brand sites and marketplaces) increase reach and data capture, and allow tighter control of merchandising and launches.
H1 2026 comparable-store sales rose 7.5%, while the footprint reached about 20,000 stores after acquisitions; same-store growth supports retail reach beyond acquired doors.
- Comparable-store sales growth+7%
- Retail stores~20,000
- Online-first competitors gaining share and lowering industry margins
- Foot-traffic declines and higher retail operating costs
- Platform dependence (search/social) increasing customer acquisition costs
- SourceEssilorLuxottica June 2026 share-capital disclosureJul 7, 2026
- SourceEssilorLuxottica Q2 and H1 2026 press releaseJul 28, 2026
- Applies to
- Direct to Consumer
- Confidence
- Durability
- medium
- Trajectory
- stableas of Oct 7, 2026
Licensing partnerships with leading fashion houses broaden premium assortment and can create quasi-exclusive access to brand IP for eyewear categories during contract terms.
The 2025 annual report confirms exclusive global licenses lasting five to 15 years and royalties of EUR249 million; renewal risk continues to limit durability.
- Royalty expense€249M-1%
- License non-renewal or renegotiation on worse terms
- Brands bringing eyewear in-house or switching licensors
- Regulatory scrutiny of exclusive distribution/licensing arrangements
Profile change log
- Oct 7, 2026 · business change
The board unanimously reaffirmed confidence in Francesco Milleri, Paul du Saillant and the group strategy after public criticism, preserving management continuity while highlighting governance tension.
- Oct 7, 2026 · business change
EssilorLuxottica launched a program to buy up to 5 million shares, creating another use of cash; the release did not specify a cancellation.
- Oct 7, 2026 · business change
A US randomized trial published in JAMA Ophthalmology reported that Stellest lenses slowed childhood myopia progression by 71% over two years, supporting the product's clinical differentiation.
- Oct 7, 2026 · business change
EssilorLuxottica acquired a meaningful stake in Top Charoen, adding Thailand's nearly 2,000-store chain to its retail reach.
- Oct 7, 2026 · analyst revision
Changed segment weights from H1 2026 to FY2025 reported revenue, added sourced moat trajectories, a bull and bear debate, management and two shared end-market profiles. Kept four claims and their strengths.
Industry & peers
Peer map
Hover a point for its values; click a peer to compare. Dashed lines: industry medians.
Global optical retail and eyewear
Consumer sales of prescription spectacles, sunglasses and readers through optical stores and online channels, including eye examinations linked to spectacles. Contact lenses, eye surgery, apparel and hearing-care treatment are outside this profile.
- EssilorLuxottica
- VSP Vision
- Warby Parker
- Zenni Optical
| Stocks | Moat | Gross m. | Op. m. | |
|---|---|---|---|---|
| EL | 83 | 60.8% | 12.5% | |
| Industry median | 10 | 82 | 61.0% | 19.8% |
| Sector median | 55 | 76 | 61.5% | 17.3% |
| All stocks median | 398 | 76 | 53.1% | 20.0% |
Moat medians cover every stock. Margin medians count only stocks with collected numbers and need at least three.
Drivers & risks
- Aging, myopia and greater awareness of eye health support recurring demand for examinations and replacement glasses.
- Insurance coverage and subscriptions can improve access and repeat visits; reimbursement rules vary by country.
- Premium lenses, recognizable brands and AI glasses can raise spending per customer, but product mix changes retail margins.
- Stores provide examinations, fitting and service, while online ordering gives consumers greater price transparency.
- Fashion and premium sunglasses are more exposed to consumer confidence and travel spending than necessary vision correction.
- Online sellers, independent opticians and other chains give consumers alternatives; a large store count does not by itself prove pricing power.
- Store rent, wages and examination staffing raise fixed costs; weak traffic reduces store productivity.
- Foreign exchange changes affect translated group results; tariffs and new wearable-product costs can offset sales growth.
- Privacy, safety and product-liability rules can constrain AI-glasses adoption; brand demand also depends on the software partner.
Bulls & bears
Can AI glasses and premium vision care increase cash profit while preserving brand demand and productivity in the core optical network?
Arguments
What to watch
- 1Comparable-store sales and wholesale constant-currency revenue
- 2Reported gross profit and wearables product mix
- 3Operating cash flow, capital expenditure and gross treasury purchases
Next check: FY2026 results: test optical and retail economics after Q3 revenue of EUR7,486m, retail comparable-store growth of 6.8%, and constant-currency myopia-management and wearables growth of 24% and 20%. Separate acquisition, currency and launch effects from retention.
Sources: company filings and dated sources collected for Find My Moat; market cap as of Nov 10, 2026. Not investment advice.
Free to reuse, commercially too, with a credit link. See the data license.
Moat Score 83/100 by <a href="https://www.findmymoat.com/stocks/XPAR:EL">Find My Moat</a> (as of September 2026)Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.